Categories: Health

Pfizer can’t sell vaccine in India as it is not ready to go for local trials

<p>
US pharma major Pfizer Inc said on Friday it had withdrawn its application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to comply with the drug regulator’s rules for carrying out a local safety and immunogenicity trial for the shots.</p>
<p>
The decision means the vaccine will not be available for sale in India in the near future.</p>
<p>
Unlike other companies such as Russia's Spuntik V who are carrying out trials in India for vaccines developed abroad, Pfizer had sought an exemption based on trials done in the United States and Germany.</p>
<p>
However, Indian rules stipulate domestic trials as well to determine if a vaccine is safe and generates an immune response in local citizens. There are, however, provisions under India’s rules to waive such trials in certain conditions.</p>
<p>
Central Drugs Standard Control Organisation said its experts did not recommend the vaccine because side effects reported abroad were still being investigated. It also said Pfizer had not proposed any plan to generate safety and immunogenicity data in India.</p>
<p>
Pfizer said, “Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time.”</p>
<p>
“Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future,” the company said.</p>
<p>
Pfizer had sought authorisation for its vaccine in India late last year, but the government in January approved two much cheaper vaccines which are being produced in India. While one is being manufactured by Pune-based Serum Institute in collaboration with UK pharma giant AstraZeneca and Oxford University, the second has been developed in India by Bharat Biotech with the Indian Council of Medical Research. Both vaccines have been cleared for emergency use.</p>
<p>
Local company Dr. Reddy’s Laboratories Ltd is running trials for Russia’s Sputnik V vaccine, which is expected to be approved in the coming weeks. The vaccine has already been cleared for mass use in Russia.</p>

IN Bureau

Recent Posts

J-K: Encounter breaks out between security forces, terrorists in Udhampur

An encounter broke out between security forces and terrorists in Jammu and Kashmir's Udhampur district,…

25 minutes ago

Canada condemns Pahalgam terror attack; Senator calls it ‘Barbaric assault on faith’

Canadian leaders have strongly condemned the recent terror attack in Pahalgam, Jammu and Kashmir, which…

1 hour ago

‘India now needs to cut Pakistan’s Jugular,” says Michael Rubin, former Pentagon official

In the aftermath of the deadly terrorist attack in Pahalgam that killed 26, Michael Rubin,…

2 hours ago

India summons Pakistan’s top diplomat in Delhi; hands over formal Persona Non Grata note for its military diplomats: Sources

India has summoned Pakistan's top diplomat in Delhi, Saad Ahmad Warraich, and handed over the…

2 hours ago

Chinese Foreign Ministry condemns attack in Jammu and Kashmir, says “China firmly opposes all forms of terrorism”

The Chinese Foreign Ministry spokesperson Guo Jiakun has condemned the terrorist attack in Jammu and…

3 hours ago

India declares Pakistani military advisors Persona Non Grata, closes Attari Check Post in wake of Pahalgam Terror Attack

The Ministry of External Affairs briefed mediapersons on Wednesday about the slew of measures announced…

3 hours ago